ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex
News Direct
Dec 21, 2023
–News Direct–
ReShape Lifesciences CEO Paul Hickey joined Steve Darling from Proactive to share significant news regarding the approval of the company's next-generation Lap-Band® 2.0 FLEX by the U.S. Food and Drug Administration.
Hickey told Proactive this FDA approval represents a historic event for ReShape Lifesciences and is expected to serve as a pivotal driver of growth for the company's Lap-Band franchise. The development of the enhanced Lap-Band 2.0 FLEX was led by physicians with a primary focus on improving the overall patient experience.
This FDA approval marks a significant milestone for ReShape Lifesciences, highlighting the company's commitment to advancing patient-centered innovations in the field of medical devices.
Contact Details
Proactive USA
+1 347-449-0879
na-editorial@proactiveinvestors.com
View source version on newsdirect.com: https://newsdirect.com/news/reshape-lifesciences-announces-fda-pma-supplement-approval-for-next-gen-lap-band-2-0-flex-672710257